Understanding your peptide pathway genetics can support a more informed conversation with your healthcare provider about GLP-1 suitability, dose titration strategy, and monitoring needs
GLP-1 receptor agonists or incretin mimetics are peptidic drugs that augment the response of GLP-1 receptors
When I counsel my patients, I tell them that the study sponsors have to escalate the dose monthly in clinical trials but that doesnt mean I have to practice medicine that way, Orandi explained to MNT
In June 2023, Pfizer announced the progress of its oral late-stage glucagon-like peptide-1 receptor agonist (GLP-1-RA) candidate toward first clinical development for the potential treatment of adults with obesity and Type 2 diabetes mellitus (T2DM)
Liposomal encapsulation further enhances this dual-action pathway by simultaneously shielding the cell from ROS and fueling ATP production
For daily formulations, aligning injection time with your most challenging eating period makes intuitive and pharmacokinetic sense